Investor Dashboard

The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after last week’s results. UBS raised its target to $12 but stayed Neutral, reflecting improving momentum but limited near‑term conviction. GuruFocus+1
Company hubSWX:GAM
Follow the latest GAM (GAM) company news, earnings coverage and investor analysis from TechStock².